The effectiveness of basic therapy in children with primary ciliary dyskinesia

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Objective. To evaluate the effectiveness of mucolytic therapy and its impact on the quality of life of children with primary ciliary dyskinesia (PCD).

Materials and methods. Analysis of discharge epicrisis of 60 children with PCD who were twice in the department of Pulmonology at the Veltischev Institute from 2023 to 2024.

Results. In children with regular therapy, there was a decrease in inflammatory markers in the blood: leukocytes from 8.1±1.28 to 6.8±1.0 thousand/ml, neutrophils from 4.3±1.1 to 3.3±0.56 thousand/ml (p<0.05). Children who had not previously received basic therapy, after initiation of daily mucolytic treatment, showed a significant increase in all indicators of external respiratory function (p<0.05). Also, in these children, the residual lung volume decreased from 196.0±47.8% to 167.0±37.8% (р<0.05). Conversely, in children with irregular therapy, residual lung volume increased from 148.0±28.3% to 172.0±37.0% (р<0.05). In children with regular therapy, the average quality of life was 73.20±6.66%, compared with 63.20±8.08% in children without basic treatment (p<0.05). Also, in these children, the indicators of the physical and psychological components of health were higher by 10% compared with children whose mucolytic therapy was insufficient: 64.0±8.73% and 74.0±7.1%, 62.0±8.32 and 72.0±7.03%, respectively (p<0.05).

Conclusion. Daily mucolytic therapy is vital to improve the condition and quality of life of children with PCD.

全文:

受限制的访问

作者简介

Yu. Mizernitskiy

N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia

编辑信件的主要联系方式.
Email: yulmiz@mail.ru
ORCID iD: 0000-0002-0740-1718
SPIN 代码: 6135-5260

Professor, MD

俄罗斯联邦, Moscow

T. Pronkina

N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia

Email: yulmiz@mail.ru
ORCID iD: 0009-0007-5811-7710
SPIN 代码: 7706-8857
俄罗斯联邦, Moscow

A. Novak

N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia

Email: yulmiz@mail.ru
ORCID iD: 0000-0001-9398-2215
SPIN 代码: 5452-7075

Candidate of Medical Science

俄罗斯联邦, Moscow

参考

  1. Despotes K.A., Zariwala M.A., Davis S.D. et al. Primary Ciliary Dyskinesia: A Clinical Review. Cells. 2024; 13 (11): 974. doi: 10.3390/cells13110974
  2. Wee W.B., Kinghorn B., Davis S.D. et al. Primary Ciliary Dyskinesia. Pediatrics. 2024; 1: 153. doi: 10.1542/peds.2023-063064
  3. Lucas J.S., Davis S.D., Omran H. et al. Primary ciliary dyskinesia in the genomics age. Lancet Respir Med. 2020; 8 (2): 202–16. doi: 10.1016/S2213-2600(19)30374-1
  4. Raidt J., Staar B.O., Omran H. et al. Primary ciliary dyskinesia. Inn Med (Heidelb). 2024; 65 (6): 545–59. doi: 10.1007/s00108-024-01726-y
  5. Paff T., Omran H., Nielsen K.G. et al. Current and Future Treatments in Primary Ciliary Dyskinesia. Int J Mol Sci. 2021; 22 (18): 9834. doi: 10.3390/ijms22189834
  6. Ferkol T. Understanding primary ciliary dyskinesia. Pediatr Pulmonol. 2025; 60 (Suppl 1): S86–S87. doi: 10.1002/ppul.27360
  7. Maglione M., Tosco A., Borrelli M. et al. Primary ciliary dyskinesia treatment: time for a new approach? Lancet Respir Med. 2024; 12 (1): 2–3. doi: 10.1016/S2213-2600(23)00236-9
  8. Adaikalam S., Gaston B. Mucus Plugging in Primary Ciliary Dyskinesia. Ann Am Thorac Soc. 2023; 20 (4): 514–5. doi: 10.1513/AnnalsATS.202301-021ED
  9. Audag N., Dubus J.C., Combret Y. Respiratory physiotherapy in pediatric practice. Rev Mal Respir. 2022; 39 (6): 547–60. doi: 10.1016/j.rmr.2022.05.001
  10. Raidt J., Brillault J., Brinkmann F. et al. Management of Primary Ciliary Dyskinesia. Pneumologie. 2020; 74 (11): 750–65. doi: 10.1055/a-1235-1520
  11. Qian L., Lam B., Zheng T. et al. Airway Clearance Techniques in Primary Ciliary Dyskinesia: A Systematic Review. P R Health Sci J. 2024; 43 (3): 119–24.
  12. Kos R., Goutaki M., Kobbernagel H.E. et al. A BEAT-PCD consensus statement: a core outcome set for pulmonary disease interventions in primary ciliary dyskinesia. ERJ Open Res. 2024; 10 (1): 00115–2023. doi: 10.1183/23120541.00115-2023
  13. Bhatt R., Hogg C. Primary ciliary dyskinesia: a major player in a bigger game. Breathe (Sheff). 2020; 16 (2): 200047. doi: 10.1183/20734735.0047-2020
  14. Пронькина Т.Н., Мизерницкий Ю.Л., Новак А.А. Влияние ежедневной муколитической терапии на качество жизни детей с первичной цилиарной дискинезией. Тез. конгр. Вельтищева. Мат-лы XXIII Росс. конгр. им. Ю.Е. Вельтищева. Инновационные технологии в педиатрии и детской хирургии. Издательство МедКом-Про, 2024; с. 241–2 [Pronkina T.N., Mizernitskii Yu.L., Novak A.A. Vliyanie ezhednevnoi mukoliticheskoi terapii na kachestvo zhizni detei s pervichnoi tsiliarnoi diskineziei. Tez. kongr. Vel'tishcheva. Mat-ly XXIII Ross. kongr. im. Yu. E. Vel'tishcheva. Innovatsionnye tekhnologii v pediatrii i detskoi khirurgii. Izdatel'stvo MedKom-Pro, 2024; рр. 241–2 (in Russ.)].
  15. Мизерницкий Ю.Л., Новак А.А., Шудуева А.Р. Опыт ингаляционного применения гипертонического раствора в пульмонологии детского возраста. Медицинский совет. 2022; 12: 36–9 [Mizernitskiy Y.L., Novak A.A., Shudueva A.R. Experience of inhaled hypertonic saline use in pediatric pulmonology. Medical Council. 2022; 12: 36–9 (in Russ.)]. doi: 10.21518/2079-701X-2022-16-12-36-39
  16. Keicho N., Hijikata M., Miyabayashi A. Impact of primary ciliary dyskinesia: Beyond sinobronchial syndrome in Japan. Respir Investig. 2024; 62 (1): 179–86. doi: 10.1016/j.resinv.2023.12.005
  17. Jenkinson C. The SF-36 physical and mental health summary measures: an example of how to interpret scores. J Health Serv Res Policy. 1998; 3 (2): 92–6. doi: 10.1177/135581969800300206
  18. Sararaks S., Azman A.B., Low L.L. et al. Validity and reliability of the SF-36: the Malaysian context. Med J Malaysia. 2005; 60 (2): 163–79.
  19. Burholt V., Nash P. Short Form 36 (SF-36) Health Survey Questionnaire: normative data for Wales. J Public Health (Oxf). 2011; 33 (4): 587–603. doi: 10.1093/pubmed/fdr006

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Russkiy Vrach Publishing House, 2025